ArticleTherapeutic advances in medical oncology2021

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.

Allen Chung-Cheng Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.